-+ 0.00%
-+ 0.00%
-+ 0.00%

Femasys Launches FemSperm Insemination Prep Kit To Boost Gynecologist Adoption Of FemaSeed Fertility Treatment

Benzinga·09/11/2025 13:05:01
Listen to the news

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced the introduction of its FemSperm Insemination Prep Kit, designed to fully enable gynecologists to perform FemaSeed Intratubal Insemination. The kit includes customized components, such as sperm washing for specific use with the FemSperm Setup kit to optimize sperm preparation for FemaSeed procedures.

This offering marks a key milestone in advancing Femasys' gynecology-focused commercialization strategy for the FemaSeed platform and supports entry into the large, underserved fertility market. By providing a streamlined, in-office solution, the company is creating the foundation for gynecologist-driven adoption of FemaSeed as a first-step fertility treatment, broadening patient access to alternatives ahead of IVF and strengthening its long-term revenue growth strategy.